EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

A REPORT ON A SERIES OF CASES OF SALIVARY GLAND LESIONS OVER A PERIOD OF 10 YEARS

Dr. Vinanti Bodele*, Dr. Devendra Palve and Dr. Deepali Mohite

ABSTRACT

Background: Salivary gland lesions have been extensively studied for the purpose of accurate diagnosis, classification, and treatment. The incidence rates of salivary gland lesions in different geographical areas and study population are yet not published extensively. Objective: To calculate the incidence rates of salivary gland lesions and correlate them with the demographical and clinical data. Study design and Setting: Retrospective study design. Materials and Methods: Data of 117 salivary gland lesions were retrieved from the archives of the department from the year 2011–2020 and the lesions were categorized into cystic, neoplastic, and tumor-like lesions. The incidence rate of each of the lesions was calculated and correlated with the demographic and clinical data of the patients. Results: Most of the lesions were categorized as mucous extravasation phenomenon (76.69%), followed by mucous retention cyst (16.5%), basal cell adenoma (2.91%), pleomorphic adenoma (1.94%), and the least occurrence was seen for necrotizing granulomatous sialadenitis and sialoliths (0.97%). The age range of the patients with mucous extravasation phenomenon was 17–30 years, while of those with mucous retention cysts was 14–33 years; for basal cell adenoma was 45–50 years, while for pleomorphic adenoma was 30–35 years, and for necrotizing granulomatous sialadenitis and sialolith were 36 years and 45 years, respectively. Except for pleomorphic adenoma, all other salivary gland lesions were predominant in males. The cystic lesions had a predilection for lower lip, benign lesions for the parotid gland, and tumor-like lesions for the submandibular salivary gland. Conclusion: Over the study duration, 3.76% of the biopsies from the head and neck lesions were diagnosed as salivary gland lesions. The commonest salivary gland lesion was mucous extravasation phenomenon and all the lesions except the pleomorphic adenoma had a male predilection.

Keywords: Sialadenitis and sialolith.

[Full Text Article] [Download Certificate]